CN116322705B - 自噬激活剂 - Google Patents

自噬激活剂

Info

Publication number
CN116322705B
CN116322705B CN202180071407.1A CN202180071407A CN116322705B CN 116322705 B CN116322705 B CN 116322705B CN 202180071407 A CN202180071407 A CN 202180071407A CN 116322705 B CN116322705 B CN 116322705B
Authority
CN
China
Prior art keywords
autophagy
salt
gene
methyl hesperidin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202180071407.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN116322705A (zh
Inventor
中上夕子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Corp
Original Assignee
Resonac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resonac Corp filed Critical Resonac Corp
Publication of CN116322705A publication Critical patent/CN116322705A/zh
Application granted granted Critical
Publication of CN116322705B publication Critical patent/CN116322705B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202180071407.1A 2020-09-17 2021-09-17 自噬激活剂 Active CN116322705B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-156459 2020-09-17
JP2020156459 2020-09-17
PCT/JP2021/034285 WO2022059775A1 (ja) 2020-09-17 2021-09-17 オートファジー活性化剤

Publications (2)

Publication Number Publication Date
CN116322705A CN116322705A (zh) 2023-06-23
CN116322705B true CN116322705B (zh) 2025-10-10

Family

ID=80776133

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180071407.1A Active CN116322705B (zh) 2020-09-17 2021-09-17 自噬激活剂

Country Status (6)

Country Link
US (1) US20230355646A1 (https=)
EP (1) EP4215199A4 (https=)
JP (1) JPWO2022059775A1 (https=)
KR (1) KR20230054431A (https=)
CN (1) CN116322705B (https=)
WO (1) WO2022059775A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022159546A (ja) * 2022-08-22 2022-10-17 功 加治佐 オートファジーとサーチュインとｉＰＳウイルス運び屋若返り不老不死薬１０

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013166744A (ja) * 2012-01-17 2013-08-29 Kao Corp 経口紫外線抵抗性向上剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944375A (ja) 1982-09-06 1984-03-12 Senjiyu Seiyaku Kk α−トコフエロ−ルリン酸エステルの安定な水溶液
US4654869A (en) 1985-09-11 1987-03-31 Itt Corporation Information collecting and forwarding apparatus
JPH0649715B2 (ja) 1987-02-10 1994-06-29 栗田工業株式会社 末端にイノシト−ル残基を結合したグルコオリゴ糖およびその製造方法
JPH0730066B2 (ja) 1988-03-09 1995-04-05 株式会社日本ハイポックス アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤
JP2747001B2 (ja) 1989-04-18 1998-05-06 昭和電工株式会社 Ｌ―アスコルビン酸―２―リン酸エステル類の製造法
JP2926412B2 (ja) 1989-05-19 1999-07-28 株式会社林原生物化学研究所 α―グリコシル―Ｌ―アスコルビン酸とその製造方法並びに用途
JPH06298783A (ja) 1993-03-31 1994-10-25 Mitsui Toatsu Chem Inc 新規なグリコシドの製造法
JP2705512B2 (ja) 1993-06-04 1998-01-28 昭和電工株式会社 Ｌ−アスコルビン酸−２−リン酸エステルの製造方法
JPH08134055A (ja) 1994-11-08 1996-05-28 Nippon High Potsukusu:Kk ３−ｏ−置換アスコルビン酸の製造方法
JPH0914705A (ja) 1995-06-29 1997-01-17 Hitachi Ltd 流体移送装置
KR20040065864A (ko) * 2003-01-16 2004-07-23 주식회사 엘지생활건강 피부알러지 완화 및 예방용 조성물
WO2010119955A1 (ja) * 2009-04-17 2010-10-21 ロート製薬株式会社 アドバンスド・グリケーション・エンド・プロダクツの蓄積による肌の老化の予防、抑制、又は改善剤
JP5735254B2 (ja) * 2009-10-22 2015-06-17 花王株式会社 経口紫外線抵抗性向上剤
WO2013018779A1 (ja) 2011-08-01 2013-02-07 株式会社林原 α－グルコシルヘスペリジンの結晶とその用途
JP6312333B2 (ja) 2013-05-10 2018-04-18 昭和電工株式会社 糖化反応抑制剤
WO2016076310A1 (ja) 2014-11-10 2016-05-19 昭和電工株式会社 保湿剤
KR20170141705A (ko) 2015-04-08 2017-12-26 바이오멘딕스, 엘엘씨 상처 치유를 조절하기 위한 제형 및 방법
JP6740354B2 (ja) 2015-10-05 2020-08-12 ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク オートファジーの流れ及びホスホリパーゼｄ及びタウを含むタンパク質凝集体のクリアランスの活性化剤ならびにタンパク質症の治療方法
JP6832113B2 (ja) * 2016-09-30 2021-02-24 小林製薬株式会社 医薬組成物
JP7136765B2 (ja) 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
CA3059461C (en) * 2017-04-12 2023-08-15 Glovia Company Limited Composition for treatment and/or prevention of alzheimer's disease
CN111051519B (zh) 2017-09-04 2024-04-26 株式会社力森诺科 肌醇衍生物的混合物
JP2020125246A (ja) * 2019-02-01 2020-08-20 花王株式会社 認知機能障害改善剤
CN110024706A (zh) 2019-03-25 2019-07-19 嘉兴市顶升杯业有限公司 一种新型宠物碗

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013166744A (ja) * 2012-01-17 2013-08-29 Kao Corp 経口紫外線抵抗性向上剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ranjitha C J et al..Neuroprotective Effect of Hesperidin Methyl Chalcone against Aluminium Chloride Induced Alzheimer's Disease: In-Silico, In-Vitro, and In-Vivo Studies.《IJPPR》.2020,第19卷(第4期),第1-24页. *
橙皮苷药理学作用机制及研究进展;李雪飞等;海南医学;20160725;第27卷(第14期);第2339页左栏 *

Also Published As

Publication number Publication date
JPWO2022059775A1 (https=) 2022-03-24
KR20230054431A (ko) 2023-04-24
WO2022059775A1 (ja) 2022-03-24
US20230355646A1 (en) 2023-11-09
EP4215199A4 (en) 2024-10-09
EP4215199A1 (en) 2023-07-26
CN116322705A (zh) 2023-06-23

Similar Documents

Publication Publication Date Title
WO2011093469A1 (ja) レドックス関連因子発現促進剤
CN116322705B (zh) 自噬激活剂
JP6406636B2 (ja) 化粧料または皮膚外用剤
US20250241937A1 (en) Cancer cell proliferation suppression agent and composition for suppressing proliferation of cancer cells
JPH11323326A (ja) 活性酸素消去剤、皮膚保全剤および変色防止剤
CN116600815A (zh) 自噬激活剂
CN116782910A (zh) 屏障功能改善剂
JP5703313B2 (ja) ３−ヒドロキシ−２−ピロンを含有する美白剤
TW202228676A (zh) 自噬活化劑
KR100836941B1 (ko) 차가버섯으로부터 분리된 항산화 화합물 및 이를 포함하는 조성물
TW202228715A (zh) 自噬活化劑
KR20040077158A (ko) 곰피 추출물로 된 항산화 및 염색체 이상 억제제
JP6345537B2 (ja) 皮膚外用剤または内用剤
TWI625133B (zh) 用於製備玻尿酸合成促進劑、HAS2mRNA表現促進劑之用途
KR20160081160A (ko) 컴파운드 k 및 파낙시돌을 함유하는 피부 보습 또는 미백용 외용제 조성물
KR20160066986A (ko) (2S)-1-O-리노레노일-3-O-β-D-갈락토피라노실-sn-글리세롤을 유효성분으로 함유하는 백모 방지용 및 백반증 개선용 조성물
KR20160081163A (ko) 컴파운드 k 및 이카리시드 b2를 함유하는 피부 보습 또는 미백용 외용제 조성물
KR20160068293A (ko) 파나세노시드를 유효성분으로 함유하는 백모 방지용 및 백반증 개선용 조성물
JP2019112363A (ja) 制御性ｔ細胞分化抑制剤、及び免疫調節用組成物
JP2005281204A (ja) 皮膚外用剤及びエラグ酸のα−配糖体
KR20160067427A (ko) (2S)-1-O-리놀레노일-2-O-리놀레노일-3-O-β-D-갈락토피라노실-sn-글리세롤을 함유하는 피부 미백용 조성물
KR20160067430A (ko) (2S)-1-O-리놀레오일-2-O-리놀레오일-3-O-β-D-갈락토피라노실-sn-글리세롤을 함유하는 피부 미백용 조성물
KR20160081169A (ko) 파낙시디올을 함유하는 피부 미백용 조성물
KR20160064496A (ko) 16-하이드록시-옥타데카-9,17-디엔-12,14-디이닐 에스테르 아세트산을 함유하는 피부 미백용 조성물
JP2015221768A (ja) 皮膚外用剤または内用剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant